Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 82,787 | 73,980 | 99,277 | 72,646 | 64,174 |
| Cost of Goods | 19,848 | 14,362 | 11,665 | 14,063 | 9,593 |
| Gross Profit | 62,939 | 59,618 | 87,612 | 58,583 | 54,581 |
| Operating Expenses | 59,474 | 64,381 | 56,220 | 56,295 | 50,644 |
| Operating Income | 4,313 | -4,401 | 32,057 | 2,351 | 4,530 |
| Interest Expense | 4,404 | 4,087 | 4,098 | 4,105 | 4,081 |
| Other Income | 1,925 | -4,247 | -1,403 | 2,835 | 3,514 |
| Pre-tax Income | 1,834 | -12,735 | 26,556 | 1,081 | 3,963 |
| Income Tax | 522 | 417 | 2,050 | 252 | 153 |
| Net Income Continuous | 1,312 | -13,152 | 24,506 | 829 | 3,810 |
| Net Income | $1,312 | $-13,152 | $24,506 | $829 | $3,810 |
| EPS Basic Total Ops | 0.01 | -0.13 | 0.24 | 0.01 | 0.04 |
| EPS Basic Continuous Ops | 0.01 | -0.13 | 0.25 | 0.01 | 0.04 |
| EPS Diluted Total Ops | 0.01 | -0.13 | 0.22 | 0.01 | 0.04 |
| EPS Diluted Continuous Ops | 0.01 | -0.13 | 0.24 | 0.01 | 0.04 |
| EBITDA(a) | $10,785 | $59 | $35,782 | $5,718 | $7,537 |